Ian O Oduor
Overview
Explore the profile of Ian O Oduor including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
5
Citations
2
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Mackay S, Oduor I, Burch T, Main B, Troyer D, Semmes O, et al.
Prostate
. 2024 May;
84(11):1067-1075.
PMID: 38734979
Introduction: Aberrant glycosylation of proteins is an important hallmark in multiple cancers. Prostate-specific membrane antigen (PSMA), a highly glycosylated protein with 10 N-linked glycosylation sites, is an Food and Drug...
2.
Mackay S, Oduor I, Burch T, Troyer D, Semmes O, Nyalwidhe J
Prostate
. 2023 Dec;
84(5):479-490.
PMID: 38151791
Introduction: Prostate-specific membrane antigen (PSMA) is a US Food and Drug Administration-approved theranostic target for prostate cancer (PCa). Although PSMA is known to be glycosylated, the composition and functional roles...
3.
Hitefield N, Mackay S, Hays L, Chen S, Oduor I, Troyer D, et al.
Biomedicines
. 2023 May;
11(4).
PMID: 37189628
Renal-cell carcinoma (RCC) is a heterogeneous disease consisting of several subtypes based on specific genomic profiles and histological and clinical characteristics. The subtype with the highest prevalence is clear-cell RCC...
4.
Burch T, Mackay S, Hitefield N, Roberts A, Oduor I, Nyalwidhe J
MicroPubl Biol
. 2022 Nov;
2022.
PMID: 36345474
Prostate cancer clinical outcomes are varied, from non-aggressive asymptomatic to lethal aggressive neuroendocrine forms which represent a critical challenge in the management of the disease. The neurofilament light ( )...
5.
Mackay S, Hitefield N, Oduor I, Roberts A, Burch T, Lance R, et al.
ACS Omega
. 2022 Sep;
7(34):29714-29727.
PMID: 36061737
The composition of N-linked glycans that are conjugated to the prostate-specific membrane antigen (PSMA) and their functional significance in prostate cancer progression have not been fully characterized. PSMA was isolated...